Shandong Aishi Biotechnology
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shandong Aishi Biotechnology between 24 Oct 2025 and 25 Nov 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
Shandong Aishi Biotechnology
Retatrutide
Tested 4 Samples
Last test 25 Nov 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Shandong Aishi Biotechnology
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
25 Nov 2025
First
24 Oct 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 Nov 2025 | View | 10mg | 10.4mg | +4.0% | 99.95% | Sep 15, 2025 | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 4 Nov 2025 | View | 10mg | 11.3mg | +13.0% | 99.60% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 29 Oct 2025 | View | 5mg | 4.78mg | -4.4% | 99.95% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 24 Oct 2025 | View | 20mg | 21.2mg | +6.0% | 99.70% | Sept 19, 2025 | No Label / Silver Crimp / Blue Cap | Lab G | Public | |